TGFBI as a candidate biomarker for non-invasive diagnosis of early-stage endometriosis.
Authors
Janša V, Pušić Novak M, Ban Frangež H, Rižner TL
Abstract
Can cartilage oligomeric matrix protein (COMP) and transforming growth factor-β-induced protein ig-h3 (TGFBI) alone or in combination with cancer antigen 125 (CA-125) be considered as potential blood biomarkers of endometriosis?
